Lonza And Genetix Biotherapeutics Extend Commercial Manufacturing Agreement For Zynteglo
09/03/2026 13:02
March 9 (Reuters) - LONZA GROUP AG LONN.S: LONZA GROUP AG - LONZA AND GENETIX BIOTHERAPEUTICS EXTEND COMMERCIAL MANUFACTURING AGREEMENT FOR ZYNTEGLO™ Source text: ID:nEQ2jBKyLa Further company coverage: BLUE.MX (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lonza AG
See all newsLonza buys 5 sites from Germany's Merck to more than double US footprint (updated)
Brief: Merck KGaA Confirms Divestment Of CDMO Business To Lonza
Lonza agrees to buy five US sites from Merck KGaA
Corrected: TABLE-Swiss trade surplus at CHF 4.35 bln in August (Sept. 17)
Table: Swiss trade surplus at CHF 1.31 bln in September